Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK
The Biomedical Catalyst is Innovate UK’s flagship grant funding mechanism, enabling small and medium sized businesses to test and develop innovative health and care solutions across life sciences, including therapeutics, medical devices, and digital health.
By awarding grants to UK-based businesses of varying stages of development, we enable them to develop innovative healthcare solutions, secure investment and speed up bringing new products to market.
The Biomedical Catalyst pilot accelerators will focus on four key themes: Children’s health, FemTech, Microbials and Neurotech, each with their own programme of support from the service providers.
Dr Samana Brannigan, Head of Health Technologies at Innovate UK, commented:
“Our vision is to inspire early-stage businesses to develop cutting edge healthcare solutions to transform healthcare and drive business growth. In collaboration with the Medical Research Council we have developed a pilot accelerator programme to maximise impact of our excellent research base and transform innovative research into commercially viable businesses. We are delighted to be working with key partners in the health and life sciences to deliver these programmes and their support will undoubtedly improve the success of the early-stage innovators in addressing real-world challenges.”
Laura Dickens, Associate Director – Industry Partnerships at Medical Research Council said:
“We are pleased to be working with Innovate UK and the Biomedical Catalyst accelerators to expand our existing support for translational research. These accelerators will enable academics to make connections with the commercial sector and access support to progress their innovative ideas towards societal and economic benefit. We look forward to seeing what ideas come forward, how they develop and the impact that is delivered.”